ArticleBioengineering (Basel, Switzerland)2022

Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.

Brian Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.